Brief: Lidds Nanozolid Technology Approved In All Countries Concerned
March 29 (Reuters) - Lidds AB LIDDS.ST :
* LIDDS INITIAL FIVE PATENT FAMILIES WHICH PROTECT DRUGS
FORMULATED WITH NANOZOLID® TECHNOLOGY ARE NOW APPROVED IN ALL
COUNTRIES CONCERNED
Source text for Eikon: ID:nGNEbCZs5Z
Further company coverage: LIDDS.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587696600;))
Recent news on Lidds AB
See all newsBrief: Liquidator To Apply For Lidds To Be Declared Bankrupt
Brief: Lidds To Delist Shares From Nasdaq First North
Brief: Lidds Proposes Voluntary Liquidation And Delisting
Brief: Lidds Decides To Terminate Process Regarding Reverse Acquisition Of Proport Invest
Brief: Lidds Signs Agreement For Reverse Takeover Of Proport Invest